Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Present at the Wells Fargo Healthcare Conference

Thursday, August 31, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. will present at the Wells Fargo Healthcare Conference on September 7, 2023, at 9:30 a.m. ET. The company's leadership, including President Paul Blanchfield and CFO Bob Marshall, will discuss its commitment to improving patient outcomes. Lantheus focuses on diagnostics, radiotherapeutics, and artificial intelligence to aid clinicians in managing disease. A live webcast of the presentation will be available on their website, with a replay accessible for 30 days post-event.
Price reaction · baseline $67.79 (2023-08-30 close) · hit after-hours · 1 other LNTH headline(s) in the window, move may be shared
day 0 close · peak
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is committed to improving patient outcomes through innovative solutions.
  • The presentation at a key healthcare conference can enhance visibility and investor interest.
  • The use of diagnostic and AI technologies showcases Lantheus's commitment to advancing medical care.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced Paul Blanchfield, President, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the Wells Fargo Healthcare Conference at 9:30 a.m. ET on Thursday, September 7.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Frequently Asked Questions

When will Lantheus present at the Wells Fargo Healthcare Conference?

Lantheus will present on Thursday, September 7, at 9:30 a.m. ET.

How can I access the live webcast of Lantheus' presentation?

You can access the live webcast in the Investors section of Lantheus' website.

How long will the webcast replay be available?

The webcast replay will be accessible for at least 30 days after the live event.

What is the focus of Lantheus as a company?

Lantheus focuses on improving patient outcomes through diagnostics and AI solutions.

Where is Lantheus headquartered?

Lantheus is headquartered in Bedford, Massachusetts.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Wells Fargo healthcare conference diagnostics radiotherapeutics
Last updated: Aug 31, 2023

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →